$IBEX

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

Original reporting
Published Sep 11, 2026, 3:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 3:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IBEX (IBEX) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$IBEXBullishMed
01

Why it matters

The earnings beat and strong FY2027 guidance could trigger a short‑term price rally, while increased capex and offshore cost pressures warrant caution.

02

Market read

First‑report earnings with record financials and bullish guidance; high relevance for traders targeting AI‑enabled BPO stocks.

03

What to watch

Higher capital expenditures and potential regulatory scrutiny of AI agents could temper growth.

Relevance 8/10Novelty 8/10Timing: after-hours earnings call

Background

IBEX (NASDAQ:IBEX) is a BPO provider expanding AI‑driven services across multiple verticals.

Company-level read

Ticker impact

$IBEXBullishHigh confidence
Context

IBEX reported record FY2026 revenue of $644.1M, adjusted EBITDA of $82.4M and issued FY2027 guidance of $700‑$715M revenue.

Expected impact

Potential price rally on the back of record results and bullish FY2027 outlook.

Evidence & confidence

Revenue and EBITDA both hit new highs, guidance exceeds prior expectations, and share repurchases signal confidence.

Market effects

Highlights growth in HealthTech and AI‑enabled BPO services, potentially benefiting peers in the outsourcing sector.

Positive for U.S. tech and health‑care service providers.

Shows demand for AI‑driven BPO globally, may influence investor sentiment toward similar firms worldwide.

Counterpoint

Guidance may be overly optimistic given rising fuel costs and offshore margin pressure.

Key entities

  • Robert T. Dechant

    Provided commentary on AI partnership and growth outlook.

  • Taylor C. Greenwald

    Discussed financial results and capital allocation.

Related articles

$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two

$NKEHighAI 8/10

Analyst warns Nike's best quarter this year may be behind it

Nike (NKE) reported Q1 earnings beating estimates, but investors sold shares. Morgan Stanley warns this may be the best quarter of the year, citing inventory risks and weaker forecasts. Nike expects fiscal 2027 revenue to decline by a high single-digit percentage. Analysts cut price targets, with Morgan Stanley suggesting a 50% drop in EPS over the next three quarters.

$CCLHighAI 8/10

Carnival (CCL) Reports Strong Q3 Earnings, Dividend Sustainabili

Carnival Corporation (CCL) reported Q3 earnings of $1.43 per share, beating estimates by $0.08. The company offers a 1.56% dividend yield with a 19% payout ratio, and its stock is fairly valued at $25.76. CCL has a GF Score of 76, reflecting strengths in profitability and valuation but weaknesses in financial strength. Institutional investors show mixed sentiment, with 9 gurus increasing positions and 4 trimming them, while insiders sold $13.5 million in shares over the past year.